Axol Bioscience
Liam has over 11 years’ C-level experience in both US listed and UK private equity environments, with an emphasis on the diagnostics, pharma and life science sectors, partnering with blue chip global organisations and start-ups alike. A true business leader, Liam spent 10 years with the BBI Group: initially as the Group CFO, before taking on the leadership of BBI Solutions as Managing Director in 2014. BBI Solutions is a leading expert in immunoassay development, biological reagents and manufacturing services. The business revenues more than doubled during his tenure, growing from £23m to over £52m, driven by solid organic growth and strategic acquisitions that built out product and service offerings to its global customer base. After leaving BBI Solutions, Liam worked as a consultant to start-ups in the diagnostics and biotech space, joining Axol Bioscience in July 2020.
Axol Bioscience
Axol Bioscience are human cell culture specialists, providing primary cells and iPSC derived cells with a wide range of functionally and physiologically, disease relevant backgrounds, together with optimised media and growth supplements. all of which are suitable for assays in basic life science research, drug discovery and toxicology assessment.